» Articles » PMID: 24189435

Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease

Overview
Specialties Biochemistry
Biophysics
Date 2013 Nov 6
PMID 24189435
Citations 552
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) exhibits extensive oxidative stress throughout the body, being detected peripherally as well as associated with the vulnerable regions of the brain affected in disease. Abundant evidence not only demonstrates the full spectrum of oxidative damage to neuronal macromolecules, but also reveals the occurrence of oxidative events early in the course of the disease and prior to the formation of the pathology, which support an important role of oxidative stress in AD. As a disease of abnormal aging, AD demonstrates oxidative damage at levels that significantly surpass that of elderly controls, which suggests the involvement of additional factor(s). Structurally and functionally damaged mitochondria, which are more proficient at producing reactive oxygen species but less so in ATP, are also an early and prominent feature of the disease. Since mitochondria are also vulnerable to oxidative stress, it is likely that a vicious downward spiral involving the interactions between mitochondrial dysfunction and oxidative stress contributes to the initiation and/or amplification of reactive oxygen species that is critical to the pathogenesis of AD.

Citing Articles

Linking Circadian Rhythms to Gut-Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease.

Su J, Zhao L, Fu R, Tang Z CNS Neurosci Ther. 2025; 31(3):e70329.

PMID: 40059063 PMC: 11890981. DOI: 10.1111/cns.70329.


Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications.

Dash U, Bhol N, Swain S, Samal R, Nayak P, Raina V Acta Pharm Sin B. 2025; 15(1):15-34.

PMID: 40041912 PMC: 11873663. DOI: 10.1016/j.apsb.2024.10.004.


Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer's Disease in Down Syndrome.

Beresford-Webb J, McAllister C, Sleigh A, Walpert M, Holland A, Zaman S Brain Sci. 2025; 15(2).

PMID: 40002463 PMC: 11853603. DOI: 10.3390/brainsci15020130.


Advances in the Regulation of Inflammatory Mediators in Nitric Oxide Synthase: Implications for Disease Modulation and Therapeutic Approaches.

Kim M, Lee J Int J Mol Sci. 2025; 26(3).

PMID: 39940974 PMC: 11818275. DOI: 10.3390/ijms26031204.


Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer's Disease: An In Vitro Study.

Rezaee N, Hone E, Sohrabi H, Abdulraheem R, Johnson S, Gunzburg S Nutrients. 2025; 17(3).

PMID: 39940374 PMC: 11820761. DOI: 10.3390/nu17030516.


References
1.
Mecocci P, MacGarvey U, Beal M . Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol. 1994; 36(5):747-51. DOI: 10.1002/ana.410360510. View

2.
Keller J, Schmitt F, Scheff S, Ding Q, Chen Q, Butterfield D . Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology. 2005; 64(7):1152-6. DOI: 10.1212/01.WNL.0000156156.13641.BA. View

3.
Chen H, Chomyn A, Chan D . Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005; 280(28):26185-92. DOI: 10.1074/jbc.M503062200. View

4.
Nunomura A, Chiba S, Lippa C, Cras P, Kalaria R, Takeda A . Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis. 2004; 17(1):108-13. DOI: 10.1016/j.nbd.2004.06.003. View

5.
Mullaart E, Boerrigter M, Ravid R, Swaab D, Vijg J . Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging. 1990; 11(3):169-73. DOI: 10.1016/0197-4580(90)90542-8. View